Dhulia I, Patel H, Chauhan N, Pardeshi N. FDA’s drug regulatory pathways, its development strategies and regulatory considerations. Int J Drug Reg Affairs [Internet]. 2021Jun.15 [cited 2024Apr.28];9(2):6-15. Available from: https://www.ijdra.com/index.php/journal/article/view/460